Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11861 | 948 | 38.0 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
415 | 2 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR | 16559 |
11861 | 1 | THERAPEUTIC PROTEIN DRUG INTERACTION//ROLLINS 5119//9000 X G SUPERNATANT | 948 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THERAPEUTIC PROTEIN DRUG INTERACTION | authKW | 128835 | 0% | 100% | 4 |
2 | ROLLINS 5119 | address | 72468 | 0% | 75% | 3 |
3 | 9000 X G SUPERNATANT | authKW | 64418 | 0% | 100% | 2 |
4 | CYTOCHROME P450 INFLAMMATION | authKW | 64418 | 0% | 100% | 2 |
5 | DISEASE DRUG INTERACTION | authKW | 64418 | 0% | 100% | 2 |
6 | PHARMACOINFORMAT MED UNIT | address | 64418 | 0% | 100% | 2 |
7 | CYTOCHROME P450 | authKW | 49863 | 12% | 1% | 114 |
8 | CYTOCHROME P4502B1 2 | authKW | 42944 | 0% | 67% | 2 |
9 | PHYSIOL PHARM CLIN | address | 42944 | 0% | 67% | 2 |
10 | CANC PHARMACOL UNIT | address | 36593 | 1% | 23% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 10836 | 62% | 0% | 584 |
2 | Toxicology | 933 | 10% | 0% | 95 |
3 | Immunology | 81 | 6% | 0% | 60 |
4 | Biochemistry & Molecular Biology | 66 | 12% | 0% | 111 |
5 | Parasitiology | 47 | 2% | 0% | 16 |
6 | Gastroenterology & Hepatology | 47 | 3% | 0% | 28 |
7 | Medicine, Research & Experimental | 45 | 4% | 0% | 36 |
8 | Biophysics | 39 | 3% | 0% | 33 |
9 | Chemistry, Medicinal | 37 | 3% | 0% | 25 |
10 | Critical Care Medicine | 20 | 1% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ROLLINS 5119 | 72468 | 0% | 75% | 3 |
2 | PHARMACOINFORMAT MED UNIT | 64418 | 0% | 100% | 2 |
3 | PHYSIOL PHARM CLIN | 42944 | 0% | 67% | 2 |
4 | CANC PHARMACOL UNIT | 36593 | 1% | 23% | 5 |
5 | BIOCHEM MKT | 32209 | 0% | 100% | 1 |
6 | BIOL EVALUAT PROD QUAL CONTROL | 32209 | 0% | 100% | 1 |
7 | BIOL SCIOSWALDO CRUZ FDN | 32209 | 0% | 100% | 1 |
8 | BIOMED CLIN SCICNR NEUROSCI | 32209 | 0% | 100% | 1 |
9 | BIOPHARMACEUT BIOPHARMACEUT | 32209 | 0% | 100% | 1 |
10 | CANC PHARAMCOL UNIT | 32209 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 27437 | 8% | 1% | 80 |
2 | BIOCHEMICAL PHARMACOLOGY | 6863 | 7% | 0% | 63 |
3 | XENOBIOTICA | 3638 | 2% | 1% | 21 |
4 | CURRENT DRUG METABOLISM | 3541 | 1% | 1% | 11 |
5 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1905 | 1% | 1% | 11 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1720 | 4% | 0% | 34 |
7 | JOURNAL OF INTERFERON RESEARCH | 1613 | 1% | 1% | 7 |
8 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1571 | 2% | 0% | 17 |
9 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 1390 | 1% | 0% | 10 |
10 | DRUG METABOLISM REVIEWS | 1155 | 1% | 1% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RENTON, KW , (2001) ALTERATION OF DRUG BIOTRANSFORMATION AND ELIMINATION DURING INFECTION AND INFLAMMATION.PHARMACOLOGY & THERAPEUTICS. VOL. 92. ISSUE 2-3. P. 147 -163 | 129 | 71% | 119 |
2 | MORGAN, ET , (1997) REGULATION OF CYTOCHROMES P450 DURING INFLAMMATION AND INFECTION.DRUG METABOLISM REVIEWS. VOL. 29. ISSUE 4. P. 1129 -1188 | 124 | 52% | 303 |
3 | RENTON, KW , (2004) CYTOCHROME P450 REGULATION AND DRUG BIOTRANSFORMATION DURING INFLAMMATION AND INFECTION.CURRENT DRUG METABOLISM. VOL. 5. ISSUE 3. P. 235-243 | 72 | 66% | 92 |
4 | EVERS, R , DALLAS, S , DICKMANN, LJ , FAHMI, OA , KENNY, JR , KRAYNOV, E , NGUYEN, T , PATEL, AH , SLATTER, JG , ZHANG, L , (2013) CRITICAL REVIEW OF PRECLINICAL APPROACHES TO INVESTIGATE CYTOCHROME P450-MEDIATED THERAPEUTIC PROTEIN DRUG-DRUG INTERACTIONS AND RECOMMENDATIONS FOR BEST PRACTICES: A WHITE PAPER.DRUG METABOLISM AND DISPOSITION. VOL. 41. ISSUE 9. P. 1598-1609 | 43 | 75% | 15 |
5 | MORGAN, ET , GORALSKI, KB , PIQUETTE-MILLER, M , RENTON, KW , ROBERTSON, GR , CHALUVADI, MR , CHARLES, KA , CLARKE, SJ , KACEVSKA, M , LIDDLE, C , ET AL (2008) REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFECTION, INFLAMMATION, AND CANCER.DRUG METABOLISM AND DISPOSITION. VOL. 36. ISSUE 2. P. 205-216 | 36 | 63% | 163 |
6 | AITKEN, AE , RICHARDSON, TA , MORGAN, ET , (2006) REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 46. ISSUE . P. 123 -149 | 56 | 37% | 175 |
7 | MORGAN, ET , (2009) IMPACT OF INFECTIOUS AND INFLAMMATORY DISEASE ON CYTOCHROME P450-MEDIATED DRUG METABOLISM AND PHARMACOKINETICS.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 85. ISSUE 4. P. 434-438 | 25 | 78% | 106 |
8 | LEE, JI , ZHANG, L , MEN, AY , KENNA, LA , HUANG, SM , (2010) CYP-MEDIATED THERAPEUTIC PROTEIN-DRUG INTERACTIONS CLINICAL FINDINGS, PROPOSED MECHANISMS AND REGULATORY IMPLICATIONS.CLINICAL PHARMACOKINETICS. VOL. 49. ISSUE 5. P. 295 -310 | 29 | 69% | 36 |
9 | RENTON, KW , (2000) HEPATIC DRUG METABOLISM AND IMMUNOSTIMULATION.TOXICOLOGY. VOL. 142. ISSUE 3. P. 173 -178 | 39 | 72% | 21 |
10 | CHRISTENSEN, H , HERMANN, M , (2012) IMMUNOLOGICAL RESPONSE AS A SOURCE TO VARIABILITY IN DRUG METABOLISM AND TRANSPORT.FRONTIERS IN PHARMACOLOGY. VOL. 3. ISSUE . P. - | 45 | 43% | 13 |
Classes with closest relation at Level 1 |